Isoxazolone Based Inhibitors of p38 MAP Kinases

Journal of Medicinal Chemistry
2008.0

Abstract

SAR of N-alkylated isoxazolones as p38 MAP kinase inhibitors was realized. The data herein show the possibility of transferring the SAR study and evaluation from N-1-substituted imidazole to isoxazolones. Optimization of substituent was realized.

Knowledge Graph

Similar Paper

Isoxazolone Based Inhibitors of p38 MAP Kinases
Journal of Medicinal Chemistry 2008.0
Novel, potent and selective anilinoquinazoline and anilinopyrimidine inhibitors of p38 MAP kinase
Bioorganic & Medicinal Chemistry Letters 2004.0
Design, Synthesis, and Biological Evaluation of Novel Tri- and Tetrasubstituted Imidazoles as Highly Potent and Specific ATP-Mimetic Inhibitors of p38 MAP Kinase: Focus on Optimized Interactions with the Enzyme’s Surface-Exposed Front Region
Journal of Medicinal Chemistry 2008.0
3,4-Diaryl-isoxazoles and -imidazoles as Potent Dual Inhibitors of p38α Mitogen Activated Protein Kinase and Casein Kinase 1δ
Journal of Medicinal Chemistry 2009.0
Design and Synthesis of Potent, Selective, and Orally Bioavailable Tetrasubstituted Imidazole Inhibitors of p38 Mitogen-Activated Protein Kinase
Journal of Medicinal Chemistry 1999.0
Unexpected Reaction of 2-Alkylsulfanylimidazoles to Imidazol-2-ones: Pyridinylimidazol-2-ones as Novel Potent p38α Mitogen-Activated Protein Kinase Inhibitors
Journal of Medicinal Chemistry 2010.0
Syntheses and structure–activity relationships for some triazolyl p38α MAPK inhibitors
Bioorganic & Medicinal Chemistry Letters 2014.0
Benzimidazolone p38 inhibitors
Bioorganic & Medicinal Chemistry Letters 2004.0
Novel Substituted Pyridinyl Imidazoles as Potent Anticytokine Agents with Low Activity against Hepatic Cytochrome P450 Enzymes
Journal of Medicinal Chemistry 2003.0
Discovery of N-substituted pyridinones as potent and selective inhibitors of p38 kinase
Bioorganic & Medicinal Chemistry Letters 2009.0